The millimeter-scale path length of these β-particles creates a beneficial “cross-fire” effect, whereby radiation from a targeted cell can also damage adjacent tumor cells that may have lower or no PSMA expression, thus helping to overcome some degree of target antigen heterogeneity [33,36,37]. This evidence concerns the gene FOLH1 and neoplasm.